manufactured
current
development
marketable
certain
financial
required
abuse
cost
develop
require
reporting
additional
approves
general
periodically
generate
applicant
manufacturing
followed
manufacture
clinical
approve
marketed
approval
generic
marketer
addition
providing
abusive
approving
included
requirement
period
product
marketing
generated
abuser
provided
drug
including
abusing
periodic
production
develops
market
sharing
following
developing
include
xtampza
price
pricing
includes
requires
report
table
follow
application
shared
sale
generating
company
provide
applicable
reported
generally
developed
provider
requiring
abuseable
manufacturer
currently
productivity
clinically
approved
share
generation
pharmaceutical
risk
abused
provides
follows
stock
